Evidence map›Paper›PMID 22908043›Full record

ArticleG3 (Bethesda, Md.)2012

Loss of a 20S proteasome activator in Saccharomyces cerevisiae downregulates genes important for genomic integrity, increases DNA damage, and selectively sensitizes cells to agents with diverse mechanisms of action.

Kevin M Doherty, Leah D Pride, James Lukose, Brian E Snydsman, Ronald Charles, Ajay Pramanik, Eric G Muller, David Botstein, Carol Wood Moore

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. A Protein in the YeastBiomolecules · 2020
    Article
  6. Article
  7. Nuclear Transport of Yeast Proteasomes.Frontiers in molecular biosciences · 2019
    Review
  8. Article
  9. Article
  10. Review
  11. Implications of Big Data for cell biology.Molecular biology of the cell · 2015
    Article
  12. Evolution of proteasome regulators in eukaryotes.Genome biology and evolution · 2015
    Article
  13. Review
  14. Ubiquitin-Proteasome System in Neurodegenerative Disorders.Journal of drug metabolism & toxicology · 2015
    Article
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Kevin M DohertyDepartment of Microbiology and Immunology, City University of New York Sophie Davis School of Biomedical Education, City College, New York, NY 10031-9101, USA.
Leah D Pride
James Lukose
Brian E Snydsman
Ronald Charles
Ajay Pramanik
Eric G Muller
David Botstein
Carol Wood Moore
City College · USUniversity of Washington · USCity College of New York · USPrinceton University · USThe Graduate Center, CUNY · US

Funding

Spatial Patterning During DevelopmentP50GM071508 · NIGMS · PRINCETON UNIVERSITY · PI POWELL, SUSAN M · 2004 to 2013
$30.6M
ZDS2P REGULATES SWE1P-DEPENDENT POLARIZED CELL GROWTH IN S CEREVISIAEP41RR011823 · NCRR · UNIVERSITY OF WASHINGTON · PI DAVIS, TRACY · 1996 to 2011
$24.7M
VOLTAGE GATING OF ION CHANNELS--SIMULATIONS AND AB INITIO CALCULATIONSS06GM008168 · NIGMS · CITY COLLEGE OF NEW YORK · PI LAKSHMAN, MAHESH K · 1989 to 2010
$17.6M
Genetics of Functional Interactions in YeastR01GM046406 · NIGMS · STANFORD UNIVERSITY · PI BOTSTEIN, DAVID · 2001 to 2015
$9.5M
NCRR NIH HHS P41 RR011823NCRR NIH HHS P41RR11823NCRR NIH HHS RR/AIO3060NIGMS NIH HHS GM08168NIGMS NIH HHS P50 GM071508NIGMS NIH HHS P50GM071508NIGMS NIH HHS R01 GM046406NIGMS NIH HHS R01GM046406NIGMS NIH HHS S06 GM008168
6 · The paper itself

Abstract

Cytoprotective functions of a 20S proteasome activator were investigated. Saccharomyces cerevisiae Blm10 and human 20S proteasome activator 200 (PA200) are homologs. Comparative genome-wide analyses of untreated diploid cells lacking Blm10 and growing at steady state at defined growth rates revealed downregulation of numerous genes required for accurate chromosome structure, assembly and repair, and upregulation of a specific subset of genes encoding protein-folding chaperones. Blm10 loss or truncation of the Ubp3/Blm3 deubiquitinating enzyme caused massive chromosomal damage and cell death in homozygous diploids after phleomycin treatments, indicating that Blm10 and Ubp3/Blm3 function to stabilize the genome and protect against cell death. Diploids lacking Blm10 also were sensitized to doxorubicin, hydroxyurea, 5-fluorouracil, rapamycin, hydrogen peroxide, methyl methanesulfonate, and calcofluor. Fluorescently tagged Blm10 localized in nuclei, with enhanced fluorescence after DNA replication. After DNA damage that caused a classic G2/M arrest, fluorescence remained diffuse, with evidence of nuclear fragmentation in some cells. Protective functions of Blm10 did not require the carboxyl-terminal region that makes close contact with 20S proteasomes, indicating that protection does not require this contact or the truncated Blm10 can interact with the proteasome apart from this region. Without its carboxyl-terminus, Blm10((-339aa)) localized to nuclei in untreated, nonproliferating (G(0)) cells, but not during G(1) S, G(2), and M. The results indicate Blm10 functions in protective mechanisms that include the machinery that assures proper assembly of chromosomes. These essential guardian functions have implications for ubiquitin-independent targeting in anticancer therapy. Targeting Blm10/PA200 together with one or more of the upregulated chaperones or a conventional treatment could be efficacious.

Indexed as

Down-RegulationAntineoplastic AgentsCell NucleusDiploidyDNA DamageEndopeptidasesG2 Phase Cell Cycle CheckpointsGenomic InstabilityMolecular ChaperonesM Phase Cell Cycle CheckpointsMutationOxidantsProteasome Endopeptidase ComplexSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsUp-RegulationAntineoplastic AgentsBlm10 protein, S cerevisiaeEndopeptidasesMolecular ChaperonesOxidantsProteasome Endopeptidase ComplexSaccharomyces cerevisiae ProteinsUBP3 protein, S cerevisiae20S proteasome activatorBLM10/PA200DNA damagemolecular chaperonesUBP3/BLM3

Identifiers

PMID22908043
PMCPMC3411250
OpenAlexW2113921433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.